✦ LIBER ✦

Gemcitabine/Cyclophosphamide/5-Fluorouracil/Folinic Acid Triplet Combination in Anthracycline- and Taxane-Refractory Breast Cancer Patients: A Southern Italy Cooperative Oncology Group Phase I/II Study

✍ Scribed by Giuseppe Frasci; Giuseppe D'Aiuto; Pasquale Comella; Renato Thomas; Immacolata Capasso; Gerardo Botti; Giuseppina Rosa Cortino; Vincenzo De Rosa; Giuseppe Cornella

Book ID: 114105272
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 1000 KB
Volume: 28
Category: Article
ISSN: 0093-7754
DOI: 10.1016/s0093-7754(01)80009-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Salvage chemotherapy with high-dose leuc

Salvage chemotherapy with high-dose leucovorin (lv) and 5-fluorouracil (5-fu) 48-hour continuous infusion (ci) in combination with conventional doses of cyclophosphamide (c) in anthracycline/taxane refractory metastatic breast cancer (mbc) patients. A phase II study

✍ Kalbakis, K.; Agelaki, S.; Androulakis, N.; Kakolyris, S.; Kouroussis, C.; Mavro 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 144 KB

A phase II trial of capecitabine in comb

A phase II trial of capecitabine in combination with the farnesyltransferase inhibitor tipifarnib in patients with anthracycline-treated and taxane-resistant metastatic breast cancer: an Eastern Cooperative Oncology Group Study (E1103)

✍ Tianhong Li, Mengye Guo, William J. Gradishar, Joseph A. Sparano, Edith A. Perez 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 301 KB